Abrdn PLC Gilead Sciences, Inc. Transaction History

Abrdn PLC

$57.3 Billion
Q2 2025

A detailed history of Abrdn PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Abrdn PLC holds 1,508,918 shares of GILD stock, worth $187 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

1,508,918

Previous 1,933,997 21.98%

Holding current value

$187 Million

Previous $217 Million 22.8%

% of portfolio

0.29%

Previous 0.43%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$96.91 - $113.0 $41.2 Million - $48 Million	-425,079 Reduced 21.98%	1,508,918 $167 Million
Q1 2025 May 13, 2025	SELL	$89.14 - $117.41 $163 Million - $215 Million	-1,833,958 Reduced 48.67%	1,933,997 $217 Million
Q4 2024 Jan 24, 2025	SELL	$83.95 - $97.9 $21.9 Million - $25.5 Million	-260,606 Reduced 6.47%	3,767,955 $348 Million
Q3 2024 Oct 24, 2024	SELL	$66.59 - $83.99 $7.56 Million - $9.53 Million	-113,485 Reduced 2.74%	4,028,561 $338 Million
Q2 2024 Aug 09, 2024	BUY	$63.15 - $72.88 $12.6 Million - $14.6 Million	199,779 Added 5.07%	4,142,046 $284 Million
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $12.8 Million - $15.6 Million	178,160 Added 4.73%	3,942,267 $289 Million
Q4 2023 Jan 31, 2024	BUY	$73.27 - $83.09 $130 Million - $147 Million	1,772,887 Added 89.04%	3,764,107 $305 Million
Q3 2023 Nov 06, 2023	BUY	$73.94 - $80.67 $60 Million - $65.5 Million	812,043 Added 68.87%	1,991,220 $149 Million
Q2 2023 Jun 20, 2024	BUY	$76.01 - $86.7 $7.11 Million - $8.11 Million	93,592 Added 8.62%	1,179,177 $90.9 Million
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $7.11 Million - $8.11 Million	93,592 Added 8.62%	1,179,177 $90.9 Million
Q1 2023 Jun 20, 2024	BUY	$77.31 - $88.08 $7.43 Million - $8.46 Million	96,077 Added 9.71%	1,085,585 $90.1 Million
Q1 2023 Apr 28, 2023	BUY	$77.31 - $88.08 $7.43 Million - $8.46 Million	96,077 Added 9.71%	1,085,585 $90.1 Million
Q4 2022 Jun 20, 2024	SELL	$62.32 - $89.47 $184 Million - $264 Million	-2,952,759 Reduced 74.9%	989,508 $84.9 Million
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $1.71 Million - $2.46 Million	-27,474 Reduced 2.7%	989,508 $84.9 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $14.8 Million - $16.9 Million	248,263 Added 32.3%	1,016,982 $62.7 Million
Q2 2022 Aug 05, 2022	SELL	$57.72 - $65.01 $831,514 - $936,534	-14,406 Reduced 1.84%	768,719 $47.5 Million
Q1 2022 May 04, 2022	SELL	$57.92 - $72.58 $12.9 Million - $16.1 Million	-221,920 Reduced 22.08%	783,125 $46.8 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $1.53 Million - $1.73 Million	23,519 Added 2.4%	1,005,045 $73 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $1.22 Million - $1.31 Million	17,960 Added 1.86%	981,526 $69.3 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $704,580 - $769,854	11,101 Added 1.17%	963,566 $66.4 Million
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $8.28 Million - $9.45 Million	138,050 Added 16.95%	952,465 $61.6 Million
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $1.44 Million - $1.64 Million	25,453 Added 3.23%	814,415 $47.4 Million
Q3 2020 Oct 21, 2020	SELL	$62.1 - $78.08 $4.65 Million - $5.85 Million	-74,896 Reduced 8.67%	788,962 $49.9 Million
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $1.7 Million - $1.97 Million	-23,448 Reduced 2.64%	863,858 $66.5 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $2.09 Million - $2.68 Million	-33,370 Reduced 3.62%	887,306 $66.3 Million
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $49,049 - $53,952	-796 Reduced 0.09%	920,676 $59.8 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $26.2 Million - $28.9 Million	-418,663 Reduced 31.24%	921,472 $58.4 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $357,546 - $400,947	5,779 Added 0.43%	1,340,135 $90.5 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $1.49 Million - $1.67 Million	23,848 Added 1.82%	1,334,356 $86.8 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $6.53 Million - $8.53 Million	-107,913 Reduced 7.61%	1,310,508 $82.6 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $13.9 Million - $15.4 Million	-195,561 Reduced 12.12%	1,418,421 $110 Million
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $8.86 Million - $10.3 Million	-136,626 Reduced 7.8%	1,613,982 $114 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $13.3 Million - $16.3 Million	-183,129 Reduced 9.47%	1,750,608 $132 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $1.23 Million - $1.45 Million	-17,339 Reduced 0.89%	1,933,737 $139 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $141 Million - $167 Million	1,951,076	1,951,076 $158 Million

Others Institutions Holding GILD

# of Institutions

2,338

Shares Held

1.03B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account